Compelling evidence supports an intimate link in time and space between eukaryotic pre-mRNA synthesis and processing and nucleocytoplasmic transport of mature mRNA. In this study, we analyzed the kinetic behavior of these processes in a quantitative manner. We used FISH and confocal scanning laser microscopy to detect transcripts produced by an inducible human cytomegalovirus immediate early (HCMV-IE) expression system. Upon induction, a large amount of pre-mRNA accumulated in nuclear foci at or near their transcription sites and, at later time, throughout the nucleoplasm. Inhibition of RNA polymerase II activity resulted in a rapid decrease in the number of transcripts in the nuclear RNA foci (half time ∼two minutes), indicating that accumulated transcripts were rapidly spliced and then released. The dispersed nucleoplasmic transcripts exited the nucleus with a half time of ∼10 minutes. Both processes were temperature dependent, suggesting that mRNA export is an active process. RNA polymerase II activation revealed that production of mature HCMV IE mRNAs required less than five minutes. Transcripts radiated from the gene at an average speed of ∼0.13 μm2/sec from this time on. Thus, it appears that these processes are tightly linked in time and space, with the splicing reaction as a rate-limiting factor.

Strong evidence supports the existence of direct and indirect connections between pre-mRNA synthesis and a number of pre-mRNA processing reactions, such as 5′cap formation, splicing and polyadenylation. The C-terminal domain (CTD) of RNA polymerase II (PolII), the enzyme complex that carries out pre-mRNA transcription, plays an important role in this (reviewed in Bentley, 1999; Hirose and Manley, 2000; Zeng and Berget, 2000). The CTD consists of an evolutionarily conserved heptad repeat with a large number of potential phosphoacceptor sites (reviewed in Dahmus, 1996). The exact sites that become phosphorylated during transcription determine the order in which RNA processing factors bind to the CTD (Komarnitsky et al., 2000; Schroeder et al., 2000). Also, different regions of the CTD have been identified that independently stimulate the three major pre-mRNA processing reactions (Fong and Bentley, 2001).

At least two mechanisms indirectly link mRNA synthesis to the transport of mature mRNAs to the cytoplasm. Both of these function through the splicing reaction and determine whether a transcript can access the nuclear export pathways of the cell. One mechanism involves splicing commitment factors (organized in spliceosomes), which actively retain intron-containing pre-mRNAs in the nucleus until the splicing process removes the remaining introns and thereby the splicing commitment factors (Chang and Sharp, 1989; Legrain and Rosbash, 1989). This step may be rate limiting in some instances. In addition, export of mRNA that is defective in splicing or 3′ end processing and synthesized from mutated expression constructs is blocked at this step (Custodio et al., 1999; Johnson et al., 2000). The second mechanism concerns the selective recruitment of specific export factors, such as the TAP protein (Grüter et al., 1998), to fully processed mRNAs (Luo and Reed, 1999). This protein contains an essential domain that functions both as a nuclear export signal and as a binding domain for components of the nuclear pores (Görlich et al., 1999; Kang and Cullen, 1999; Katahira et al., 1999).

These intimate relationships between RNA synthesis, RNA processing and RNA transport are also reflected in the spatial-temporal organization of the genes and factors involved in these processes. Nascent transcripts are confined to several thousand nucleoplasmic sites or ‘transcription factories’ (Fay et al., 1997) (reviewed in Jackson et al., 2000). Each factory contains ∼30 active polymerases with their associated transcripts (Jackson et al., 1998). Efficient processing of these transcripts requires the recruitment of splicing factors such as SF2/ASF to sites of active genes in vivo (Misteli et al., 1997; Misteli and Spector, 1999; Eils et al., 2000). It has been proposed that a large number of these components pre-assemble into a transcription/processing complex, followed by the recruitment or transport of this complex to the active genes (Gall et al., 1999). The large subunit of the elongating form of PolII and several splicing factors are present in numerous nuclear domains or ‘speckles’ at the light microscope resolution level in addition to a diffuse nucleoplasmic staining (Spector, 1993; Bregman et al., 1995; Mortillaro et al., 1996; Zeng et al., 1997). Moreover, the activity and localization of splicing factors is determined by their phosphorylation state (Misteli and Spector, 1998).

When a particular gene is transcribed at a high level, new transcripts may accumulate at or near the transcription site in foci that have an elongated dot or track-like appearance. This has been shown for endogenous genes such as human collagen 1α1 and β-actin (Xing et al., 1995; Femino et al., 1998) and for integrated viral genes (Lawrence et al., 1989; Dirks et al., 1997). In these cases, the active gene is often localized at one extreme of an elongated dot. This suggests that the majority of mRNAs in the elongated dot are detached from the gene. Although the majority of RNA processing is supposed to occur cotranscriptionally, elongated dots may represent sites in which pre-mRNA processing is completed or may represent an early stage of RNA export (Dirks et al., 1997; Johnson et al., 2000; Melcák et al., 2000). In rat 9G cells, which we use in this study, it has been demonstrated that nuclear foci contain HCMV IE RNA exon and intron sequences as well as splicing factors. The splicing reaction is therefore thought to continue within the elongated dot-like structures (Raap et al., 1991; Dirks et al., 1997; Snaar et al., 1999).

In this study, we use a quantitative method based on fluorescent in situ hybridization (FISH) in combination with confocal scanning laser microscopy (CSLM) to investigate the spatial and temporal relationships of HCMV IE mRNA synthesis and nuclear export in response to inactivation and activation of PolII. On the basis of these measurements we show that nuclear HCMV IE transcripts represent two subpopulations with distinct kinetic behavior, namely those in nuclear foci (at or near the transcription site) and those dispersed throughout the nucleoplasm.

Cell culture, induction and inhibition of rat 9G cells

Rat 9G cells are transfected rat fibroblasts that contain an integrated tandem repeat of 50 copies of the HCMV immediate early gene (Boom et al., 1986; Van de Corput et al., 1998). Cells were grown to subconfluency on sterile uncoated microscope glass slides in Dulbecco’s Modified Eagle (DME) medium, without phenol red, containing 4.5 mg/ml glucose and 110 g/ml sodium pyruvate, supplemented with 10% fetal calf serum (FCS), 0.03% glutamine and 1000 U/ml penicillin/streptomycin. All reagents were obtained from Life Technologies, Rockville, MD. Cells were cultured at 37°C in a 5% CO2 atmosphere. Cells were incubated in medium containing 50 μg/ml cycloheximide for four to six hours to induce expression of the HCMV-IE gene. Induction occurred in approximately 30% of the cells and was S-phase dependent (Boom et al., 1986, Boom et al., 1988; Dirks and Raap, 1995). RNA polymerase II activity was inhibited by addition of either 500 ng/ml Actinomycin D (AMD) or 25 μg/ml 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) to the culture medium. Both inhibitors were purchased from Sigma (Sigma Aldrich, St. Louis, MI, USA). In some experiments, DRB was removed after various incubation periods to recover PolII activity.

Cell fixation and in situ hybridization

Cells were fixed and permeabilized as described (Dirks et al., 1993). Briefly, rat 9G cells were washed in PBS for 10 seconds and fixed with 3.7% formaldehyde (Merck, Darmstadt, Germany) containing 5% acetic acid in PBS for 15 minutes at room temperature. Cells were subsequently washed twice in PBS and stored in 70% ethanol at 4°C. Prior to hybridization, cells were washed in deionized water and pretreated with 0.1% pepsin (Sigma) in 0.01 M HCL for 30 seconds at 37°C. Cells were then washed in deionized water, dehydrated in a graded ethanol series and air-dried to prevent uncontrolled dilution of probes. Detection of HCMV-IE mRNA by DNA probes was carried out with plasmid pSS containing the 5.0 kb SphI-SalI genomic fragment of the immediate-early region (Boom et al., 1986). Probes for intron 1 and exon 4 sequences were generated by PCR from plasmid pSS with specific primers. Probes were labeled with digoxigenin-, biotin- or FITC-dUTP by nick translation (Roche Diagnostics GmbH, Mannheim, Germany) and purified over PCR purification columns according to instructions provided by the manufacturer (Qiagen, Venlo, the Netherlands). Probes were dissolved in 60% deionised formamide, 2×SSC (0.3 M NaCl, 0.03 M Na-citrate), 10 mM EDTA, 25 mM NaH2PO4 pH 7.4, 10% dextran sulfate and 250 ng/μl sheared herring sperm DNA at a final concentration of 5 ng/μl. Glass slides containing rat 9G cells were fixed, pretreated with pepsin and hybridized with a probe as described previously (Dirks et al., 1993). Probe and target sequences were denatured simultaneously by placing the slides on an 80°C metal plate for two minutes. Hybridizations were performed at 37°C overnight in a moist chamber.

Previously, we have shown that the hybridization patterns obtained by this procedure were very similar to those obtained when cells are submitted to a much stronger fixation procedure and examined by electron microscopy (Macville et al., 1995).

Post-hybridization washes and immunofluorescence

Cells were washed three times in 60% formamide, 2×SSC for 10 minutes each at 37°C and two times five minutes in Tris-buffered saline (TBS: 150 mM NaCl, 100 mM Tris-CL pH 7.4) containing 0.05% Tween 20 (Biorad, Hercules, California, USA) at room temperature. Digoxygenin-labeled probes were detected by anti-digoxin monoclonal antibody (Sigma Aldrich, St. Louis, MA, USA; dilution 1:1000) followed by goat anti-mouse Alexa594 (Molecular Probes Inc. Eugene, OR; dilution 1:500). Probes labeled with biotin were detected by Streptavidine-Alexa594 (Molecular Probes Inc. Eugene, OR, USA; dilution 1:400). All antibodies were diluted in TNB (TBS containing 0.5% (w/v) blocking reagent (Roche Diagnostics GmbH, Mannheim, Germany)) and incubated for 45 minutes at 37°C. Cells were dehydrated through a graded ethanol series and mounted in Vectashield (Vector Laboratories, Inc., Burlingame, California, USA) containing 50 μg/ml 4′,6′-diamidino-2-phenyl indole (DAPI) as a DNA counterstain.

Microscopy and quantification of fluorescence by confocal scanning laser microscopy

Fluorescence microscopy was carried out with a Leica DM epifluorescence microscope equipped with a 100 W mercury arc lamp and appropriate filter sets. Digital images were captured with a cooled CCD camera (Photometrics, Tucson, Arizona, USA) and processed using SCIL-image (Multihouse, Amsterdam, the Netherlands) and Adobe Photoshop. Confocal images were recorded on a Leica TCS confocal scanning laser microscope (CSLM) (Leica Microsystems, Heidelberg, Germany) equipped with a 100×PL APO NA 1.4 Leica objective and an Argon/Krypton laser at an excitation wavelength of 567 nm. Image stacks of expressing and non-expressing cells in the same visual field were collected for quantitative analysis of the integrated fluorescence intensity in accumulations of HCMV IE transcripts (nuclear foci) and in the remainder of the nucleus in such a manner that saturation of the recorder (photomultiplyer tube) did not take place. The laser intensity and scanning speed were kept constant to avoid the interference of different levels of photobleaching during the measurements. The integrated fluorescence intensity in specified regions (of known area) of the nucleus was calculated in three-dimensional representations of the nucleus on the basis of the collected image stacks, which is a feature included in the Leica TCS NT software package. Additional calculations were carried out in Microsoft Excel. The integrated fluorescence intensity in the HCMV DNA integration site in non-induced cells was used as a reference, as all cells contain the same integrated tandem repeat of HCMV genes. All values were averaged over five to 10 cells. These cells were randomly chosen from the pool of HCMV IE expressing cells. Differential interference contrast images were also recorded for each cell to provide information about intracellular structures.

To assess the amounts of HCMV IE transcripts in the nuclei of rat 9G cells after induction by cycloheximide, we performed FISH and quantitative CSLM and calculated the integrated fluorescence intensity in 3D representations of two distinct subnuclear domains, namely RNA foci (containing accumulated transcripts at or near the transcription site) and remainder of the nucleus (see Materials and Methods). The transcription inhibitors DRB and AMD were used at concentrations specific for PolII. The adenosine analogue DRB prevented the essential conversion of hypo-phosphorylated PolIIA to elongating PolIIO through inhibition of the TFIIH-associated kinase CAK (Yankulov et al., 1995). As this mechanism is reversible, removal of DRB results in the initiation of gene expression. AMD functions through an irreversible mechanism, intercalating the DNA strands (Perry and Kelley, 1970).

After inhibition of PolII, HCMV IE transcripts exit more rapidly from nuclear foci than from the diffuse nucleoplasmic pool

As integrated fluorescence intensity in the nuclear RNA foci decreased approximately threefold within 10 minutes of inhibition of PolII activity, the half time of this process is approximately two minutes (Fig. 1A; Table 1). The ratio of transcribed intron 1 sequences and transcribed total HCMV-IE sequences remained constant throughout the foci at all time-points (data not shown). This suggests that the release of transcripts from the RNA foci correlated with the completion of the splicing reaction (Dirks and Raap, 1995; Snaar et al., 1999). After ∼30 minutes, the level of fluorescence in the track was comparable to that in the integration site, indicating that no or only a few transcripts are present at the transcription site. The integrated fluorescence intensity of the dispersed nuclear transcripts decreased with much slower rates (Fig. 1B; Table 1) after PolII inactivation (half time of ∼10 min). After ∼120 minutes, the nuclei of these cells reached an integrated fluorescence intensity closely resembling that of HCMV-IE negative cells. The inhibitory mechanism of PolII did not seem to influence the kinetics of these processes, as the integrated fluorescent intensity decreased with similar kinetics whether PolII was inhibited by AMD or by DRB (Table 1).

Activation of PolII results in rapid accumulation of HCMV IE transcripts at the transcription site. Transcripts then exit from the transcription site in a radial pattern

Coordinated activation of HCMV IE gene transcription was achieved by the removal of DRB from the incubation medium of rat 9G cells. As described above, a large majority of HCMV-IE transcripts had exited from the nucleus after 120 minutes of DRB inhibition. In this manner, it became feasible to analyze the kinetics of HCMV-IE transcription before the steady-state situation (accumulated transcripts in foci and transcripts dispersed through the nucleoplasm) was established. These experiments demonstrated that the HCMV-IE integration site gained RNA fluorescence at one minute after PolII activation (Fig. 2A; Table 1). Activation of transcription was therefore extremely rapid. Accumulation of transcripts in a nuclear focus or dot larger than the integration site was found after approximately three minutes. The continuing increase in fluorescent intensity with time resulted after approximately five minutes in the radial dispersion of HCMV IE transcripts from the nuclear RNA foci into the surrounding nucleoplasm. The amount of radiating transcripts increased at longer times (seven to 15 minutes), as did the average distance of the transported transcripts from the transcription site. The amount of transcripts in the remainder of the nucleoplasm also increased with time but at a slower rate (Fig. 2B; Table 1). Approximately 30 minutes after PolII activation, HCMV-IE transcripts were present throughout the nucleus. Transcripts were also detectable in the cytoplasm of newly HCMV-IE-expressing cells at this time. Accumulation of large amounts of transcripts in the entire nucleoplasm and in the cytoplasm occurred at longer intervals (60 minutes) of PolII activity.

Incubation at 4°C interrupts processing and transport of HCMV IE mRNA in a nearly complete, but reversible manner

Rat 9G cells were incubated at 4°C to determine if pre-mRNA processing and nucleocytoplasmic mRNA transport were energy-dependent processes. These experiments demonstrated that the integrated fluorescence intensity of pre-mRNA transcripts at the transcription site remained relatively constant over a period of two hours when PolII inhibition was carried out at 4°C (Fig. 3A; Table 1). A similar situation was observed for the amount of diffusely distributed nucleoplasmic transcripts (Fig. 3B; Table 1). Subsequent return of the rat 9G cells to an incubation temperature of 37°C resulted in a rapid decrease in the amount of transcripts accumulated at the transcription site and in the amount of dispersed nucleoplasmic transcripts. Fick’s law predicts a decrease in diffusion rate of only ∼10% as a result of a decrease in temperature from 37°C to 4°C. This can therefore not explain the magnitude of the difference that was observed in these experiments. We therefore concluded that the interruption of pre-mRNA processing at the transcription site and of mRNA export to the nucleus was fully reversible. This was also supported by the kinetics of these decreases in integrated fluorescence intensity, as they were very similar to the kinetics for PolII inhibition at 37°C (Fig. 3A,B; Table 1).

In the current study, we have analyzed the kinetics of HCMV IE mRNA synthesis, processing and transport in rat 9G cells. Initiation of PolII activity in rat 9G cells by DRB removal was shown to result in a rapid onset of mRNA synthesis (within two minutes). This can occur through two mechanisms. Hypophosphorylated PolIIA may be rapidly recruited to a pre-initiation complex at the moment the gene becomes activated. Alternatively, a pre-initiation complex containing PolIIA may already be present at the site of the inactive gene. In either case, the removal of DRB allows transcription initiation and the subsequent phosphorylation of PolIIA to elongating PolIIO. PolIIA did not colocalize with the transcriptionally inactive HCMV IE gene in rat 9G cells (Snaar et al., 1999), which renders the second hypothesis less likely.

The kinetics of HCMV IE activation in rat 9G cells are in agreement with the kinetics of β-actin gene activation in rat kidney cells (Femino et al., 1998). In both cell types, the number of transcripts at the transcription site increases in a linear fashion during the first five minutes of gene activation. At this time, transcripts become visible in nuclear RNA foci or elongated dots. Mature mRNAs are detected in our system at nuclear sites distinct from, but surrounding, the nuclear RNA foci from five minutes onwards. This implies that both transcription and pre-mRNA processing of the newly transcribed ∼6 kb HCMV IE messengers can be completed within five minutes. Comparison with the reported rates of PolII transcription, which are 1.7-2.5 kb/min for human PolII (Tennyson et al., 1995) and ∼1.1-1.4 kb/min for rat PolII (Femino et al., 1998), suggests that most or all of this time will be required for mRNA transcription. Pre-mRNA processing must therefore be mostly cotranscriptional in these early phases of transcription.

Inactivation of RNA PolII by DRB or AMD results in the disappearance of accumulated HCMV IE transcripts with a calculated half time of approximately two minutes. Melcák et al. (Melcák et al., 2000) observed a similar reduction in the amount of Epstein-barr virus mRNA, as judged qualitatively by the length of the elongated dots that accumulated at transcription sites in Namalwa cells after DRB or AMD inhibition. As efficient release of transcripts from the spliceosome requires the completion of pre-mRNA processing (Custodio et al., 1999), the decrease in the rate of integrated fluorescence intensity appears to mirror the rate at which the remaining introns are removed from the accumulated transcripts. Several protein factors may be involved in this transient immobilization of transcripts at and near the transcription site. It may involve splicing commitment factors, but it may also be a function of RNA PolII, which remains present in a complex with splicing factors after termination of transcription (Snaar et al., 1999). The subsequent release of spliced transcripts from spliceosomes may involve putative RNA helicases (Company et al., 1991; Ohno and Shimura, 1996; Schwer and Meszaros, 2000) and the small GTPase Ran (Grimm et al., 1997). Concomitant with RNA synthesis and processing, the cap-binding proteins, the poly(A)-binding protein PABP2 and various other mRNA-binding proteins associate with mRNAs to mediate their transport (Visa et al., 1996; Calado et al., 2000; Huang and Steitz, 2001; Le Hir et al., 2001; Lei et al., 2001). The capacity of these processes may also be exceeded by the transcription rate of the HCMV IE gene, possibly resulting in the saturation of the entire transport system. Interestingly, yeast strains carrying mutations in mRNA nuclear export factors were shown to accumulate mature mRNAs in foci that coincide with sites of transcription (Jensen et al., 2001).

Monitoring the decrease in nuclear fluorescence after treatment of rat 9G cells with DRB revealed that HCMV-IE mRNA export takes place with a half time of ∼10 minutes. Previously, mRNA export from oocyte nuclei had been reported with half times of 2.4 minutes (Dargemont and Kühn, 1992) and 30 minutes (Jarmolowski et al., 1994). The half-time value measured in this study is consistent with the value measured by Jarmolowski et al. (Jarmolowski et al., 1994), considering the fact that the diameter of an oocyte nucleus is at least five times larger than the diameter of a rat fibroblast nucleus. Differences in transport rates may also be caused by discrepancies in the nuclear complexity and the compactness in these cell types. Transport of in vitro transcribed mRNA in oocyte nuclei was analyzed upon microinjection. Interestingly, Jarmolowski et al. (Jarmolowski et al., 1994) measured a lag time of 20-25 minutes before export of mRNA. It is likely that this period was needed to assemble a transport-competent complex. Apparently, the formation of such a complex is much more efficient when coupled to transcription, as HCMV-IE transcripts are exported from the gene within five minutes of the initiation of transcription. This is also consistent with data presented by Pallavicini et al. (Pallavicini et al., 1994), who studied c-myc expression under control of a heat shock promoter in CHO-like cells. Upon heat shock, c-myc transcripts started to accumulate in cell nuclei within 10 minutes and remained there, but after returning the cells to 37°C it took them one hour to be transported to cytoplasm. This suggests that either splicing or the formation of transport-competent complexes does not occur during heat shock.

As previously described, HCMV-IE transcripts radiate in all directions upon release from the transcription site and are eventually present throughout the nucleoplasm in a punctate pattern (Dirks and Raap, 1995; Macville et al., 1996). Transcripts are detected at increasing distances from the transcription site at increasing transcription times and throughout the nucleoplasm after approximately 30 minutes. A diffusion rate of ∼0.13 μm2/sec is calculated for this process. Much faster rates of RNA transport have been reported by Politz et al. (Politz et al., 1999) using hybridizing oligo (dT) labeled with chemically masked fluorescein to nuclear poly(A) RNA followed by spot photolysis and recording the distribution of fluorescence. After uncaging fluorescein, fluorescence spread within 30 seconds in all directions throughout the nucleus at a calculated diffusion rate of 0.6 μm2/sec. It was therefore concluded that mRNA export is a process of free diffusion, which does not require energy. It should be noted, however, that there exist many different types of poly(A) RNA in the cell nucleus that are poorly characterized. For example, it is still not known what type of poly(A) RNA is present in speckle domains containing splicing factors and other processing and transcription factors. Earlier, Politz et al. (Politz et al., 1998) measured a broader range of diffusion rates by fluorescence correlation microscopy, suggesting that different pools of poly(A) RNA that do not all necessarily leave the cell nucleus but may move at fast speed may indeed exist. The mRNAs in transit to the cytoplasm may move at a much slower speed because they are packed in an RNP particle (Singh et al., 1999). Miralles et al. (Miralles et al., 2000) demonstrated that Balbiani Ring RNP particles do not always diffuse freely through the nucleoplasm. Instead, they have been observed to interact with fibers of specific structure and composition (Miralles et al., 2000). Notably, poly(A) RNA was shown to move in nuclei at a rate consistent with free diffusion but they did not accumulate in the cytoplasm. We observed that fluorochrome-labeled poly (dT) hybridized to poly (A) RNA in living cells was poorly exported towards the cytoplasm, indicating that hybridized mRNAs may escape from the regular transport mechanism (C. Molenaar, H.J.T. and R.W.D., unpublished).

Furthermore, our results and those of others indicate that mRNA export is at some stage energy dependent because transport is blocked when cells are incubated at 4°C or at slightly lower temperature (Dargemont and Kühn, 1992; Jarmalowski et al., 1994; Melcák et al., 2001). Consistent with these observations, Calado et al. (Calado et al., 2000) reported that no transport of PABP2 to the cytoplasm takes place at 4°C. Another argument opposing a free diffusion model of RNA export is the presence of nucleoplasmic structures that at some stage mediate RNA export by transient interactions [for example see Strambio-de-Castillia et al. (Strambio-de-Castillia et al., 1999)]. In conclusion, this study demonstrates that levels of transcription, pre-mRNA processing and transport of HCMV IE mRNA are rapidly regulated in response to inhibition or activation of PolII. These processes are tightly linked in time and space. Furthermore, our results indicate that nucleocytoplasmic transport of these transcripts may occur in an energy-dependent active process.

Fig. 1.

Inhibition of RNA polymerase II activity by DRB or AMD treatment. (A) Integrated fluorescent intensity of HCMV IE transcripts accumulated in the nuclear foci relative to the integration site. Addition of either RNA polymerase II inhibitor resulted in a rapid decrease (half time ∼2 minutes) in the amount of HCMV IE transcripts accumulated in nuclear foci. (B) Integrated fluorescent intensity of HCMV IE transcripts dispersed through the nucleoplasm relative to negative nuclei. The amount of HCMV IE mRNAs in the remainder of the nucleoplasm decreased at a much slower rate (half time ∼10 minutes). (C) CSLM images of cells at different times after RNA polymerase II inactivation. After induction of the HCMV IE gene expression by cycloheximide, transcripts were present in nuclear foci and also dispersed throughout the nucleoplasm. These images demonstrate the decrease in the amount of transcripts in the nuclear foci and in the nucleoplasm at different intervals after addition of a RNA polymerase II inhibitor. At all times, HCMV IE transcripts were observed in the cytoplasm.

Fig. 1.

Inhibition of RNA polymerase II activity by DRB or AMD treatment. (A) Integrated fluorescent intensity of HCMV IE transcripts accumulated in the nuclear foci relative to the integration site. Addition of either RNA polymerase II inhibitor resulted in a rapid decrease (half time ∼2 minutes) in the amount of HCMV IE transcripts accumulated in nuclear foci. (B) Integrated fluorescent intensity of HCMV IE transcripts dispersed through the nucleoplasm relative to negative nuclei. The amount of HCMV IE mRNAs in the remainder of the nucleoplasm decreased at a much slower rate (half time ∼10 minutes). (C) CSLM images of cells at different times after RNA polymerase II inactivation. After induction of the HCMV IE gene expression by cycloheximide, transcripts were present in nuclear foci and also dispersed throughout the nucleoplasm. These images demonstrate the decrease in the amount of transcripts in the nuclear foci and in the nucleoplasm at different intervals after addition of a RNA polymerase II inhibitor. At all times, HCMV IE transcripts were observed in the cytoplasm.

Fig. 2.

Activation of RNA polymerase II by removal of DRB. (A) Integrated fluorescent intensity of HCMV IE transcripts accumulated in the nuclear foci relative to the integration site. Removal of DRB resulted in a rapid accumulation of HCMV IE mRNAs at nuclear foci. (B) Integrated fluorescent intensity of HCMV IE transcripts dispersed through the nucleoplasm relative to negative nuclei. The amount of HCMV IE mRNAs in the remainder of the nucleoplasm increased at a slower rate after DRB removal. Transcripts radiating from the nuclear foci were observed from approximately 5 minutes onwards. (C) CSLM images of cells at different times after RNA polymerase II inactivation. After induction of the HCMV IE gene expression by cycloheximide, transcripts were present in nuclear foci and also dispersed throughout the nucleoplasm. Two hours of DRB inhibition removed virtually all transcripts from the nucleus. Subsequent removal of DRB resulted in a fast increase of fluorescent intensity at nuclear foci (∼3 minutes and later), followed by the nucleoplasm. Untreated cells were not subjected to cycloheximide or DRB treatment; therefore these cells did not express the HCMV IE genes.

Fig. 2.

Activation of RNA polymerase II by removal of DRB. (A) Integrated fluorescent intensity of HCMV IE transcripts accumulated in the nuclear foci relative to the integration site. Removal of DRB resulted in a rapid accumulation of HCMV IE mRNAs at nuclear foci. (B) Integrated fluorescent intensity of HCMV IE transcripts dispersed through the nucleoplasm relative to negative nuclei. The amount of HCMV IE mRNAs in the remainder of the nucleoplasm increased at a slower rate after DRB removal. Transcripts radiating from the nuclear foci were observed from approximately 5 minutes onwards. (C) CSLM images of cells at different times after RNA polymerase II inactivation. After induction of the HCMV IE gene expression by cycloheximide, transcripts were present in nuclear foci and also dispersed throughout the nucleoplasm. Two hours of DRB inhibition removed virtually all transcripts from the nucleus. Subsequent removal of DRB resulted in a fast increase of fluorescent intensity at nuclear foci (∼3 minutes and later), followed by the nucleoplasm. Untreated cells were not subjected to cycloheximide or DRB treatment; therefore these cells did not express the HCMV IE genes.

Fig. 3.

Effect of incubation temperature on the amount of HCMV IE transcripts after RNA polymerase II inhibition by DRB. (A) Integrated fluorescent intensity of HCMV IE transcripts accumulated in the nuclear foci relative to the integration site. The mRNA amount in the nuclear foci remained relatively constant during incubation of cells with DRB at 4°C. Shifting cells back to 37°C restored the previously observed decrease in integrated fluorescence intensity (half time ∼2 minutes). (B) Integrated fluorescent intensity of HCMV IE transcripts dispersed through the nucleoplasm relative to negative nuclei. The mRNA amount in the remainder of the nucleoplasm remained relatively constant during incubation of cells with DRB at 4°C. Shifting cells back to 37°C restored the previously observed decrease in integrated fluorescence intensity (half time ∼10 minutes). (C) CSLM images of cells at different incubation temperatures during intervals of DRB treatment. After induction of the HCMV IE gene expression by cycloheximide at 37°C, transcripts were observed in nuclear foci and in the remainder of the nucleoplasm. These transcripts remained present when incubation with DRB was carried out at 4°C. Subsequent incubation at 37°C resulted in a decrease in integrated fluorescence intensities with similar kinetics to cells treated with DRB at 37°C only.

Fig. 3.

Effect of incubation temperature on the amount of HCMV IE transcripts after RNA polymerase II inhibition by DRB. (A) Integrated fluorescent intensity of HCMV IE transcripts accumulated in the nuclear foci relative to the integration site. The mRNA amount in the nuclear foci remained relatively constant during incubation of cells with DRB at 4°C. Shifting cells back to 37°C restored the previously observed decrease in integrated fluorescence intensity (half time ∼2 minutes). (B) Integrated fluorescent intensity of HCMV IE transcripts dispersed through the nucleoplasm relative to negative nuclei. The mRNA amount in the remainder of the nucleoplasm remained relatively constant during incubation of cells with DRB at 4°C. Shifting cells back to 37°C restored the previously observed decrease in integrated fluorescence intensity (half time ∼10 minutes). (C) CSLM images of cells at different incubation temperatures during intervals of DRB treatment. After induction of the HCMV IE gene expression by cycloheximide at 37°C, transcripts were observed in nuclear foci and in the remainder of the nucleoplasm. These transcripts remained present when incubation with DRB was carried out at 4°C. Subsequent incubation at 37°C resulted in a decrease in integrated fluorescence intensities with similar kinetics to cells treated with DRB at 37°C only.

Table 1.
graphic
graphic

This study was partly supported by the Dutch Science Organization, project number 901-34-144 and project number 901-34-151.

Bentley, D. (
1999
). Coupling RNA polymerase II transcription with pre-mRNA processing.
Curr. Opin. Cell Biol
.
11
,
347
-351.
Boom, R., Geelen, G. L., Sol, C. J., Raap, A. K., Minnaar, R. P., Klaver, B. P. and van der Noordaa, J. (
1986
). Establishment of a rat cell line inducible for the expression of human cytomegalovirus immediate early gene products by protein synthesis inhibitors.
J. Virol
.
58
,
851
-859.
Boom, R., Sol, C. J. A., Minnaar, R. P., Geelen, G. L. M. C., Raap, A. K. and van der Noordaa, J. (
1988
). Induction of gene expression under human cytomegalovirus immediate early enhancer-promoter control by inhibition of protein synthesis is cell cycle-dependent.
J. Gen. Virol
.
69
,
1179
-1193.
Bregman, D. B., Du, L., van der Zee, S. and Warren, S. L. (
1995
). Transcription-dependent redistribution of the large subunit of RNA polymerase II to discrete nuclear domains.
J. Cell Biol
.
129
,
287
-298.
Calado, A. and Carmo-Fonseca, M. (
2000
). Localization of poly(A)-binding protein 2 (PABP2) in nuclear speckles is independent of import into the nucleus and requires binding to poly(A) RNA.
J. Cell Sci
.
113
,
2309
-2318.
Chang, D. D. and Sharp, P. A. (
1989
). Regulation by HIV Rev depends upon recognition of splice sites.
Cell
59
,
789
-795.
Company, M., Arenas, J. and Abelson, J. (
1991
). Requirement of the RNA helicase-like protein PRP22 for release of messenger RNA from spliceosomes.
Nature
349
,
487
-493.
Custodio, N., Carmo-Fonseca, M., Geraghty, F., Pereira, H. S., Grosveld, F. and Antoniou, M. (
1999
). Inefficient processing impears release of RNA from the site of transcription.
EMBO J
.
18
,
2855
-2866.
Dahmus, M. E. (
1996
). Reversible phosphorylation of the C-terminal domain of RNA polymerase II.
J. Biol. Chem
.
271
,
19009
-19012.
Dargemont, C. and Kühn, L. C. (
1992
). Export of mRNA from microinjected nuclei of Xenopus laevis oocytes.
J. Cell Biol
.
118
,
1
-9.
Dirks, R. W. and Raap, A. K. (
1995
). Cell-cycle-dependent gene expression studied by two-colour fluorescent detection of a mRNA and histone mRNA.
Histochem. Cell Biol
.
104
,
391
-395.
Dirks, R. W., van de Rijke, F. M., Fujishita, S., van der Ploeg, M. and Raap, A. K. (
1993
). Methodologies for specific intron and exon RNA localization in cultured cells by haptenized and fluorochromized probes.
J. Cell Sci
.
104
,
1187
-1197.
Dirks, R. W., de, Pauw, E. S. and Raap, A. K. (
1997
). Splicing factors associate with nuclear HCMV-IE transcripts after transcriptional activation of the gene, but dissociate upon transcription inhibition: evidence for a dynamic organization of splicing factors.
J. Cell Sci
.
110
,
515
-522.
Eils, R., Gerlich, D., Tvaruko, W., Spector, D. L. and Misteli, T. (
2000
). Quantitative imaging of pre-mRNA splicing factors in living cells.
Mol. Biol. Cell
11
,
413
-418.
Fay, F. S., Taneja, K. L., Shenoy, S., Lifshitz, L. and Singer, R. H. (
1997
). Quantitative digital analysis of diffuse and concentrated nuclear distributions of nascent transcripts, SC35 and poly(A).
Exp. Cell Res
.
231
,
27
-37.
Femino, A. M., Fay, F. S., Fogarty, K. and Singer, R. H. (
1998
). Visualization of single RNA transcripts in situ.
Science
280
,
585
-590.
Fong, N. and Bentley, D. L. (
2001
). Capping, splicing, and 3′ processing are independently stimulated by RNA polymerase II: different functions for different segments of the CTD.
Genes Dev
.
15
,
1783
-1795.
Gall, J. G., Bellini, M., Wu, Z. and Murphy, C. (
1999
). Assembly of the nuclear transcription and processing machinery: Cajal bodies (coiled bodies) and transcriptosomes.
Mol. Biol. Cell
10
,
4385
-4402.
Görlich, D. and Kutay, U. (
1999
). Transport between the cell nucleus and the cytoplasm.
Annu. Rev. Cell Dev. Biol
.
15
,
607
-660.
Grimm, C., Lund, E. and Dahlberg, J. E. (
1997
). Selection and nuclear immobilization of exportable RNAs.
Proc. Natl. Acad. Sci. USA
94
,
10122
-10127.
Grüter, P., Tabernero, C., von Kobbe, C., Schmitt, C., Saavedra, C., Bachi, A., Wilm, M., Felber, B. K. and Izaurralde, E. (
1998
). TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus.
Mol. Cell
1
,
649
-659.
Hirose, Y. and Manley, J. L. (
2000
). RNA polymerase II and the integration of nuclear events.
Genes Dev
.
14
,
1415
-1429.
Huang, Y. and Steitz, J. A. (
2001
). Splicing factors SR20 and 9G8 promote the nucleocytoplasmic export of mRNA.
Mol. Cell
7
,
899
-905.
Jackson, D. A., Iborra, F. J., Manders, E. M. and Cook, P. R. (
1998
). Numbers and organization of RNA polymerases, nascent transcripts, and transcription units in HeLa nuclei.
Mol. Biol. Cell
9
,
1523
-1536.
Jackson, D. A., Pombo, A. and Iborra, F. (
2000
). The balance sheet for transcription: an analysis of nuclear RNA metabolism in mammalian cells.
FASEB J
.
14
,
242
-254.
Jarmolowski, A., Boelens, W. C., Izaurralde, E. and Mattaj, I. W. (
1994
). Nuclear export of different classes of RNA is mediated by specific factors.
J. Cell Biol
.
124
,
627
-635.
Jensen, T. H., Patricio, K., McCarthy, T. and Rosbash, M. (
2001
). A block to mRNA nuclear export in S. cerevisiae leads to hyperadenylation of transcripts that accumulate at the site of transcription.
Mol. Cell
7
,
887
-898.
Johnson, C., Primorac, D., McKinstry, M., McNeil, J., Rowe, D. and Lawrence, J. B. (
2000
). Tracking COL1A1 RNA in osteogenesis imperfecta: splice-defective transcripts initiate transport from the gene but are retained within the SC35 domain.
J. Cell Biol
.
150
,
417
-431.
Kang, Y. and Cullen, B. R. (
1999
). The human Tap protein is a nuclear mRNA export factor that contains novel RNA-binding and nucleocytoplasmic transport sequences.
Genes Dev
.
13
,
1126
-1139.
Katahira, J., Strasser, K., Podtelejnikov, A., Mann, M., Jung, J. U. and Hurt, E. (
1999
). The Mex67p-mediated nuclear mRNA export pathway is conserved from yeast to human.
EMBO J
.
18
,
2593
-2609.
Komarnitsky, P., Cho, E. J. and Buratowski, S. (
2000
). Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription.
Genes Dev
.
14
,
2452
-2460.
Lawrence, J. B., Singer, R. H. and Marselle, L. M. (
1989
). Highly localized tracks of specific transcripts within interphase nuclei visualized by in situ hybridization.
Cell
57
,
493
-502.
Le Hir, H., Gatfield, D., Izaurralde, E. and Moore, M. J. (
2001
). The exon-exon junction complex provides a binding olatform for factors involved in mRNA export and nonsense-mediated mRNA decay.
EMBO J
.
20
,
4987
-4997.
Legrain, P. and Rosbash, M. (
1989
). Some cis- and trans-acting mutants for splicing target pre-mRNA to the cytoplasm.
Cell
57
,
573
-583.
Lei, E. P., Krebber, H. and Silver, P. A. (
2001
). Messenger RNAs are recruited for nuclear export during transcription.
Genes Dev
.
15
,
1771
-1782.
Luo, M. J. and Reed, R. (
1999
). Splicing is required for rapid and efficient mRMA export in metazoans.
Proc. Natl. Acad. Sci. USA
96
,
14937
-14942.
Macville, M. V., Van Dorp, A. G., Wiesmeijer, K. C., Dirks, R. W., Fransen, J. A. and Raap, A. K. (
1995
). Monitoring morphology and signal during non-radioactive in situ hybridization procedures by reflection-contrast microscopy and transmission electron microscopy.
J. Histochem. Cytochem
.
43
,
665
-674.
Macville, M. V., Van Dorp, A. G., Dirks, R. W., Fransen, J. A. and Raap, A. K. (
1996
). Evaluation of pepsin treatment for electron microscopic RNA in situ hybridization on ultra-thin cryosections of cultured cells.
Histochem. Cell Biol
.
105
,
139
-145.
Melcák, I., Cermanová, S., Jirsová, K., Koberna, K., Malínsky, J. and Raška, I. (
2000
). Nuclear pre-mRNA compartmentalization: trafficking of released transcripts to splicing factor reservoirs.
Mol. Biol. Cell
11
,
497
-510.
Melčák, I., Melčákova,., Kopsky, V., Večeřová, J. and Raška, I. (
2001
). Prespliceosomal assembly on microinjected precursor mRNA takes place in nuclear speckles.
Mol. Biol. Cell
12
,
393
-406.
Miralles, F., Öfverstedt, L. G., Nafiseh, S., Aisouni, Y. and Hellman, U. (
2000
). Electron tomography reveals posttranscriptional binding of pre-mRNPs to specific fibers in the nucleoplasm.
J. Cell Biol
.
148
,
271
-282.
Misteli, T., Caceres, J. F. and Spector, D. L. (
1997
). The dynamics of a pre-mRNA splicing factor in living cells.
Nature
387
,
523
-527.
Misteli, T. and Spector, D. L. (
1998
). The cellular organization of gene expression.
Curr. Opin. Cell Biol
.
10
,
323
-331.
Misteli, T. and Spector, D. L. (
1999
). RNA polymerase II targets pre-mRNA splicing factors to transcription sites in vivo.
Mol. Cell
3
,
697
-705.
Mortillaro, M. J., Blencowe, B. J., Wei, X., Nakayasu, H., Du, L., Warren, S. L., Sharp, P. A. and Berezney, R. (
1996
). A hyperphosphorylated form of the large subunit of RNA polymerase II is associated with splicing complexes and the nuclear matrix.
Proc. Natl. Acad. Sci. USA
93
,
8253
-8257.
Ohno, M. and Shimura, Y. (
1996
). A human RNA helicase-like protein, HRH1, facilitates nuclear export of spliced mRNA by releasing the RNA from the spliceosome.
Genes Dev
.
10
,
997
-1007.
Pallavicini, M. G., George, T., Deteresa, P. S., Amendola, R. and Gray, J. W. (
1994
). Intracellular dynamics of c-myc mRNA traffic in single cells in situ.
J. Cell. Physiol
.
158
,
223
-230.
Perry, R. P. and Kelley, D. E. (
1970
). Inhibition of RNA synthesis by actinomycin D: characteristic dose-response of different RNA species.
J. Cell Physiol
.
76
,
127
-140.
Politz, J. C., Browne, E. S., Wolf, D. E. and Pederson, T. (
1998
). Intranuclear diffusion and hybridization state of oligonucleotides measured by fluorescence correlation spectroscopy in living cells.
Proc. Natl. Acad. Sci. USA
95
,
6043
-6048.
Politz, J. C., Tuft, R. A., Pederson, T. and Singer, R. H. (
1999
). Movement of nuclear poly(A) RNA throughout the interchromatin space in living cells.
Curr. Biol
.
9
,
285
-291.
Raap, A. K., van de Rijke, F. M., Dirks, R. W., Sol, C. J., Boom, R. and van der Ploeg, M. (
1991
). Bicolor fluorescence in situ hybridization to intron and exon mRNA sequences.
Exp. Cell Res
.
197
,
319
-322.
Schroeder, S. C., Schwer, B., Shuman, S. and Bentley, D. (
2000
). Dynamic association of capping enzymes with transcribing RNA polymerase II.
Genes Dev
.
14
,
2435
-2440.
Schwer, B. and Meszaros, T. (
2000
). RNA helicase dynamics in pre-mRNA splicing.
EMBO J
.
19
,
6582
-6591.
Singh, O. P., Bjorkroth, B., Masich, S., Wieslander, L. and Daneholt, B. (
1999
). The intranuclear movement of Balbiani ring premessenger ribonucleoprotein particles.
Exp. Cell Res
.
251
,
135
-146.
Snaar, S. P., Vincent, M. and Dirks, R. W. (
1999
). RNA polymerase II localizes at sites of human cytomegalovirus immediate-early RNA synthesis and processing.
J. Histochem. Cytochem
.
47
,
245
-254.
Spector, D. L. (
1993
). Nuclear organization of pre-mRNA processing.
Curr. Opin. Cell Biol
.
5
,
442
-447.
Strambio-de-Castillia, C. and Rout, M. P. (
1999
). TAPping into transport.
Nat. Cell Biol
.
1
,
E31
-E33.
Tennyson, C. N., Klamut, H. J. and Worton, R. G. (
1995
). The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced.
Nat. Genet
.
9
,
184
-190.
Van de Corput, M. P. C., Dirks, R. W., van Gijlswijk, R. P. M., van de Rijke, F. M. and Raap, A. K. (
1998
). Fluorescence in situ hybridization using horseradish peroxidase labeled oligonucleotides and tyramide signal amplification for sensitive DNA and mRNA detection.
Histochem. Cell Biol
.
110
,
431
-437.
Visa, N., Izaurralde, E., Ferreira, J., Daneholt, B. and Mattaj, I. W. (
1996
). A nuclear cap-binding complex binds Balbiani ring pre-mRNA cotranscriptionally and accompanies the ribonucleoprotein particle during nuclear export.
J. Cell Biol
.
133
,
5
-14.
Xing, Y., Johnson, C. V., Moen, P. T. Jr, McNeil, J. A. and Lawrence, J. B. (
1995
). Nonrandom gene organization: structural arrangements of specific pre-mRNA transcription and splicing with SC-35 domains.
J. Cell Biol
.
131
,
1635
-1647.
Yankulov, K., Yamashita, K., Roy, R., Egly, J. M. and Bentley, D. L. (
1995
). The transcriptional elongation inhibitor 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase.
J. Biol. Chem
.
270
,
23922
-23925.
Zeng, C. and Berget, S. M. (
2000
). Participation of the C-terminal domain of RNA polymerase II in exon definition during pre-mRNA splicing.
Mol. Cell. Biol
.
20
,
8290
-8301.